Illumina Inc.

About Illumina Inc.

Illumina is dedicated to improving human health by unlocking the power of the genome. Their mission is to push the boundaries of genomic possibility, enabling researchers and clinicians to accelerate discoveries and applications for health and environmental benefits.

Products & Services

Sequencing Platforms:A range of next-generation sequencing (NGS) systems from benchtop to production scale, including the MiSeq i100 Series and NovaSeq X, offering simplicity and speed.

Microarray Scanners and Kits:Tools for genetic analysis on any scale, driving imaging accuracy and exceptional results.

Library Preparation Kits:Optimized workflows for diverse DNA and RNA inquiries, including single-cell RNA-Seq with Illumina Single Cell 3' RNA Prep.

Software & Analysis Tools:Comprehensive bioinformatics suite including BaseSpace Sequence Hub, DRAGEN Secondary Analysis, and Illumina Connected Analytics for deeper insights and data management.

Services:Includes sequencing and microarray services, proactive instrument monitoring, and training to support research and clinical applications.

Popular Products:Highlighted offerings like AmpliSeq for Illumina, Illumina Complete Long Reads, and TruSight Oncology Product Family for specific genomic needs.

Specialties

Next-Generation Sequencing (NGS) Microarray Technology Genomic Data Analysis Single-Cell RNA Sequencing Clinical and Translational Genomics Precision Health

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Stock Purchase T: - FT: Stock Purchase	A: 5000000 MR: - FA: 5 Million FAN: 5000000	D: 2025-07-22 FD: 2025-07-22	1 investors

Stock Purchase Latest

2025-07-22

$5.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jacob Thaysen

Chief Executive Officer

F

Freda Lewis-Hall

MD, DFAPA, MFPM

G

Glenn Cohen

Deputy Dean and Professor of Law at Harvard Law School and the Faculty Director for the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

L

Leslie Biesecker

Clinical and Molecular Geneticist

N

Nita Farahany

Robinson O. Everett Professor of Law and Philosophy and Director of Duke Science and Society Initiative

S

Scott Gottlieb

Chair of the Board

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Illumina Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised